The Oslo longitudinal recovery study
About the project
This is a research project on first-episode psychosis involving Vestre Viken Hospital Trust studying the role of neurocognition and resilience as predictors for remission and full recovery of the disorder during a 10-year follow up with annual assessments.
Twenty-eight patients and 28 matched controls are included. The MATRICS Consensus Cognitive Battery is used to measure neurocognitive function.
The results may identify characteristics of persons who recover and thereby generate increased knowledge of heterogeneity in schizophrenia and the possibilities of recovery.
This is an on-going research project with national and international collaborators.
Standardized clinical instruments as well as consensus based definitions of remission and full recovery are used.